PLX logo

Protalix BioTherapeutics (PLX) Net Income

Annual Net Income

$8.31 M
+$23.24 M+155.68%

December 31, 2023

Summary

Performance

1-Year Change

+155.68%

3-Year Change

+227.43%

5-Year Change

+131.42%

15-Year Change

+109.96%

PLX Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

85.46%
PLX annual net profit is higher than 85.46% of companies in Healthcare sector

High & Low

All-time High

$58.04 M
PLX annual net profit is currently -85.68% below its historical high of $58.04 million

3-Year Low

-$27.58 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
PLX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 14, 2025
PLX next annual earnings announcement is scheduled for Mar 14, 2025

OtherPLXprofitabilitymetrics:

Annual Net Margin

12.69%
PLX annual net profit margin is 12.69%

Annual Revenue

$65.49 M
PLX annual revenue is $65.49 million

Annual Gross Profit

$42.51 M
PLX annual gross profit is $42.51 million

Annual EPS

$0.09
PLX annual earnings per share is $0.09

Quarterly Net Income

$3.24 M
+$5.44 M+246.89%

September 30, 2024

Summary

Performance

3-Month Change

+246.89%

1-Year Change

+274.73%

3-Year Change

+274.73%

5-Year Change

+274.73%

PLX Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

83.07%
PLX quarterly net profit is higher than 83.07% of companies in Healthcare sector

High & Low

All-time High

$72.90 M
PLX quarterly net profit is currently -95.56% below its historical high of $72.90 million

3-Year Low

-$6.67 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
PLX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 14, 2025
PLX next earnings announcement is scheduled for Mar 14, 2025

OtherPLXprofitabilitymetrics:

Quarterly Net Margin

18.02%
PLX quarterly net profit margin is 18.02%

Quarterly Revenue

$17.96 M
PLX quarterly revenue is $17.96 million

Quarterly Gross Profit

$9.58 M
PLX quarterly gross profit is $9.58 million

Quarterly EPS

$0.03
PLX quarterly earnings per share is $0.03

TTM Net Income

-$9.61 M
+$5.09 M+34.63%

September 30, 2024

Summary

Performance

3-Month Change

+34.63%

1-Year Change

-190.49%

3-Year Change

-190.49%

5-Year Change

-190.49%

PLX TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

69.09%
PLX TTM net profit is higher than 69.09% of companies in Healthcare sector

High & Low

All-time High

$58.04 M
PLX TTM net profit is currently -116.55% below its historical high of $58.04 million

3-Year Low

-$27.58 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
PLX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 14, 2025
PLX next earnings announcement is scheduled for Mar 14, 2025

OtherPLXprofitabilitymetrics:

Annual Net Margin

12.69%
PLX annual net profit margin is 12.69%

TTM Revenue

$45.67 M
PLX TTM revenue is $45.67 million

TTM Gross Profit

$16.38 M
PLX TTM gross profit is $16.38 million

TTM EPS

-$0.16
PLX TTM earnings per share is -$0.16

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

Annual Net Income

$8.31 M
PLX annual net profit is $8.31 million

Annual Revenue

$65.49 M
PLX annual revenue is $65.49 million

Annual Cost Of Goods Sold

$22.98 M
PLX annual cost of goods sold is $22.98 million

Annual Operating Expenses

$32.05 M
PLX annual total operating expenses is $32.05 million

Annual Interest Expense

$3.18 M
PLX annual interest expense is $3.18 million

Annual Income Tax

$254.00 K
PLX annual income tax is $254.00 thousand

PLX Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+155.7%+274.7%-190.5%
3 y3 years+227.4%+274.7%-190.5%
5 y5 years+131.4%+274.7%-190.5%

PLX Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+130.1%-83.3%+148.5%-190.5%+65.2%
5 y5-yearat high+130.1%-83.3%+128.8%-190.5%+65.2%
alltimeall time-85.7%+110.0%-95.6%+105.5%-116.5%+88.5%

Protalix BioTherapeutics Net Income History

DateAnnualQuarterlyTTM
Sep 2024
-
$3.24 M(-246.9%)
-$9.61 M(-34.6%)
Jun 2024
-
-$2.20 M(-52.1%)
-$14.69 M(-314.6%)
Mar 2024
-
-$4.59 M(-24.0%)
$6.85 M(-17.6%)
Dec 2023
$8.31 M(-155.7%)
-$6.04 M(+226.3%)
$8.31 M(-21.7%)
Sep 2023
-
-$1.85 M(-109.6%)
$10.62 M(+19.3%)
Jun 2023
-
$19.34 M(-717.7%)
$8.90 M(-156.4%)
Mar 2023
-
-$3.13 M(-16.3%)
-$15.77 M(+5.7%)
Dec 2022
-$14.93 M(-45.9%)
-$3.74 M(+4.9%)
-$14.93 M(-16.4%)
Sep 2022
-
-$3.57 M(-33.1%)
-$17.85 M(-3.4%)
Jun 2022
-
-$5.33 M(+133.3%)
-$18.49 M(-24.2%)
Mar 2022
-
-$2.29 M(-65.7%)
-$24.39 M(-11.6%)
Dec 2021
-$27.58 M(+322.8%)
-$6.67 M(+58.8%)
-$27.58 M(+34.4%)
Sep 2021
-
-$4.20 M(-62.6%)
-$20.52 M(-1.1%)
Jun 2021
-
-$11.24 M(+105.3%)
-$20.76 M(+51.9%)
Mar 2021
-
-$5.47 M(-1479.1%)
-$13.66 M(+109.5%)
Dec 2020
-$6.52 M(-64.3%)
$397.00 K(-108.9%)
-$6.52 M(-1.6%)
Sep 2020
-
-$4.44 M(+6.9%)
-$6.63 M(+15.2%)
Jun 2020
-
-$4.15 M(-349.0%)
-$5.75 M(-38.4%)
Mar 2020
-
$1.67 M(+472.9%)
-$9.35 M(-48.9%)
Dec 2019
-$18.28 M(-30.9%)
$291.00 K(-108.2%)
-$18.28 M(-23.9%)
Sep 2019
-
-$3.56 M(-54.0%)
-$24.00 M(-6.8%)
Jun 2019
-
-$7.74 M(+6.6%)
-$25.76 M(-2.7%)
Mar 2019
-
-$7.26 M(+33.7%)
-$26.48 M(+0.1%)
Dec 2018
-$26.46 M(-68.3%)
-$5.43 M(+2.1%)
-$26.46 M(-22.9%)
Sep 2018
-
-$5.32 M(-37.1%)
-$34.33 M(-15.1%)
Jun 2018
-
-$8.46 M(+16.9%)
-$40.44 M(+28.3%)
Mar 2018
-
-$7.24 M(-45.6%)
-$31.53 M(-62.2%)
Dec 2017
-$83.44 M(+184.1%)
-$13.30 M(+16.3%)
-$83.44 M(+14.7%)
Sep 2017
-
-$11.44 M(-2641.6%)
-$72.76 M(+6.0%)
Jun 2017
-
$450.00 K(-100.8%)
-$68.61 M(-14.1%)
Mar 2017
-
-$59.15 M(+2154.1%)
-$79.92 M(+172.1%)
Dec 2016
-$29.36 M(-150.6%)
-$2.62 M(-64.0%)
-$29.36 M(-163.6%)
Sep 2016
-
-$7.29 M(-32.8%)
$46.16 M(-7.0%)
Jun 2016
-
-$10.85 M(+26.2%)
$49.63 M(-10.4%)
Mar 2016
-
-$8.60 M(-111.8%)
$55.41 M(-4.5%)
Dec 2015
$58.04 M(-293.8%)
$72.90 M(-2008.4%)
$58.04 M(-348.7%)
Sep 2015
-
-$3.82 M(-24.7%)
-$23.33 M(-15.2%)
Jun 2015
-
-$5.07 M(-15.1%)
-$27.52 M(-3.7%)
Mar 2015
-
-$5.97 M(-29.5%)
-$28.57 M(-4.6%)
Dec 2014
-$29.94 M(+7.7%)
-$8.47 M(+5.7%)
-$29.94 M(-7.5%)
Sep 2014
-
-$8.01 M(+30.9%)
-$32.36 M(+7.5%)
Jun 2014
-
-$6.12 M(-16.7%)
-$30.10 M(-2.3%)
Mar 2014
-
-$7.34 M(-32.5%)
-$30.81 M(+10.9%)
Dec 2013
-$27.79 M(+139.2%)
-$10.88 M(+89.4%)
-$27.79 M(+3.8%)
Sep 2013
-
-$5.75 M(-15.9%)
-$26.78 M(+1.0%)
Jun 2013
-
-$6.84 M(+58.2%)
-$26.51 M(+164.2%)
Mar 2013
-
-$4.32 M(-56.3%)
-$10.04 M(-13.6%)
Dec 2012
-$11.62 M(-68.2%)
-$9.88 M(+80.3%)
-$11.62 M(+9.0%)
Sep 2012
-
-$5.48 M(-156.8%)
-$10.65 M(-24.2%)
Jun 2012
-
$9.64 M(-263.3%)
-$14.05 M(-62.4%)
Mar 2012
-
-$5.90 M(-33.8%)
-$37.38 M(+2.3%)
Dec 2011
-$36.53 M
-$8.91 M(+0.4%)
-$36.53 M(+1.1%)
Sep 2011
-
-$8.88 M(-35.2%)
-$36.14 M(+21.5%)
DateAnnualQuarterlyTTM
Jun 2011
-
-$13.69 M(+171.0%)
-$29.74 M(+14.0%)
Mar 2011
-
-$5.05 M(-40.8%)
-$26.09 M(-10.0%)
Dec 2010
-$29.00 M(-7.8%)
-$8.53 M(+244.7%)
-$29.00 M(-18.1%)
Sep 2010
-
-$2.47 M(-75.4%)
-$35.41 M(-8.8%)
Jun 2010
-
-$10.04 M(+26.2%)
-$38.83 M(+13.5%)
Mar 2010
-
-$7.96 M(-46.7%)
-$34.21 M(+8.8%)
Dec 2009
-$31.44 M(+40.3%)
-$14.94 M(+153.4%)
-$31.44 M(+36.2%)
Sep 2009
-
-$5.89 M(+8.6%)
-$23.08 M(-2.5%)
Jun 2009
-
-$5.43 M(+4.7%)
-$23.68 M(+5.3%)
Mar 2009
-
-$5.18 M(-21.2%)
-$22.48 M(+0.3%)
Dec 2008
-$22.41 M(-30.1%)
-$6.58 M(+1.2%)
-$22.41 M(-26.7%)
Sep 2008
-
-$6.50 M(+53.6%)
-$30.57 M(+6.1%)
Jun 2008
-
-$4.23 M(-17.3%)
-$28.82 M(-14.6%)
Mar 2008
-
-$5.11 M(-65.3%)
-$33.75 M(+5.2%)
Dec 2007
-$32.08 M(+241.7%)
-$14.73 M(+210.5%)
-$32.08 M(+54.1%)
Sep 2007
-
-$4.75 M(-48.2%)
-$20.81 M(+12.1%)
Jun 2007
-
-$9.15 M(+165.3%)
-$18.57 M(+44.6%)
Mar 2007
-
-$3.45 M(-0.4%)
-$12.84 M(+17.3%)
Dec 2006
-$9.39 M(+63.4%)
-$3.46 M(+38.6%)
-$10.95 M(-16.9%)
Sep 2006
-
-$2.50 M(-27.1%)
-$13.18 M(+23.0%)
Jun 2006
-
-$3.43 M(+119.8%)
-$10.71 M(+46.8%)
Mar 2006
-
-$1.56 M(-72.6%)
-$7.29 M(+27.0%)
Dec 2005
-$5.75 M(+137.3%)
-$5.69 M(>+9900.0%)
-$5.75 M(+144.8%)
Sep 2005
-
-$31.90 K(+149.2%)
-$2.35 M(-0.5%)
Jun 2005
-
-$12.80 K(+23.1%)
-$2.36 M(-1.9%)
Mar 2005
-
-$10.40 K(-99.5%)
-$2.40 M(-0.7%)
Dec 2004
-$2.42 M(+1620.7%)
-$2.29 M(+5194.5%)
-$2.42 M(+1285.8%)
Sep 2004
-
-$43.30 K(-26.0%)
-$174.70 K(+6.7%)
Jun 2004
-
-$58.50 K(+119.1%)
-$163.70 K(+21.3%)
Mar 2004
-
-$26.70 K(-42.2%)
-$135.00 K(-4.1%)
Dec 2003
-$140.70 K(-6.1%)
-$46.20 K(+43.0%)
-$140.80 K(-2.4%)
Sep 2003
-
-$32.30 K(+8.4%)
-$144.30 K(+0.1%)
Jun 2003
-
-$29.80 K(-8.3%)
-$144.20 K(-1.6%)
Mar 2003
-
-$32.50 K(-34.6%)
-$146.60 K(-2.2%)
Dec 2002
-$149.80 K(-54.5%)
-$49.70 K(+54.3%)
-$149.90 K(-4.1%)
Sep 2002
-
-$32.20 K(0.0%)
-$156.30 K(-9.3%)
Jun 2002
-
-$32.20 K(-10.1%)
-$172.40 K(-10.5%)
Mar 2002
-
-$35.80 K(-36.2%)
-$192.70 K(-41.5%)
Dec 2001
-$329.20 K(+211.7%)
-$56.10 K(+16.1%)
-$329.20 K(-2.5%)
Sep 2001
-
-$48.30 K(-8.0%)
-$337.70 K(+21.9%)
Jun 2001
-
-$52.50 K(-69.5%)
-$277.00 K(+17.1%)
Mar 2001
-
-$172.30 K(+166.7%)
-$236.50 K(+124.0%)
Dec 2000
-$105.60 K(-89.4%)
-$64.60 K(-621.0%)
-$105.60 K(-74.8%)
Sep 2000
-
$12.40 K(-203.3%)
-$418.30 K(-34.8%)
Jun 2000
-
-$12.00 K(-71.0%)
-$641.70 K(-3.8%)
Mar 2000
-
-$41.40 K(-89.0%)
-$667.30 K(-33.1%)
Dec 1999
-$997.90 K(-13.0%)
-$377.30 K(+78.8%)
-$998.00 K(+60.8%)
Sep 1999
-
-$211.00 K(+461.2%)
-$620.70 K(+51.5%)
Jun 1999
-
-$37.60 K(-89.9%)
-$409.70 K(+10.1%)
Mar 1999
-
-$372.10 K
-$372.10 K
Dec 1998
-$1.15 M(-1068.6%)
-
-
Dec 1997
$118.40 K(-10.1%)
-
-
Dec 1996
$131.70 K
-
-

FAQ

  • What is Protalix BioTherapeutics annual net profit?
  • What is the all time high annual net income for Protalix BioTherapeutics?
  • What is Protalix BioTherapeutics annual net income year-on-year change?
  • What is Protalix BioTherapeutics quarterly net profit?
  • What is the all time high quarterly net income for Protalix BioTherapeutics?
  • What is Protalix BioTherapeutics quarterly net income year-on-year change?
  • What is Protalix BioTherapeutics TTM net profit?
  • What is the all time high TTM net income for Protalix BioTherapeutics?
  • What is Protalix BioTherapeutics TTM net income year-on-year change?

What is Protalix BioTherapeutics annual net profit?

The current annual net income of PLX is $8.31 M

What is the all time high annual net income for Protalix BioTherapeutics?

Protalix BioTherapeutics all-time high annual net profit is $58.04 M

What is Protalix BioTherapeutics annual net income year-on-year change?

Over the past year, PLX annual net profit has changed by +$23.24 M (+155.68%)

What is Protalix BioTherapeutics quarterly net profit?

The current quarterly net income of PLX is $3.24 M

What is the all time high quarterly net income for Protalix BioTherapeutics?

Protalix BioTherapeutics all-time high quarterly net profit is $72.90 M

What is Protalix BioTherapeutics quarterly net income year-on-year change?

Over the past year, PLX quarterly net profit has changed by +$5.09 M (+274.73%)

What is Protalix BioTherapeutics TTM net profit?

The current TTM net income of PLX is -$9.61 M

What is the all time high TTM net income for Protalix BioTherapeutics?

Protalix BioTherapeutics all-time high TTM net profit is $58.04 M

What is Protalix BioTherapeutics TTM net income year-on-year change?

Over the past year, PLX TTM net profit has changed by -$20.22 M (-190.49%)